Mikhail Blagosklonny is an Oncology professor at Roswell Park Cancer Institute, Buffalo, in NY, U.S.A. He has carried out numerous research programs on cancer. His major focus is on molecular and cellular biology. Mikhail concentrates more on Ontogenesis and tumor suppressors, signal transduction, and cell cycle. He has put a lot of emphasis in his study on mitosis, apoptosis, and anticancer therapeutics to translate basic science into new anticancer strategies. Some of those include exploiting cancer cells cell cycling and drug resistance for selective protection of normal cells. His study has also included other age-related diseases as well as age itself. In his effort to deal with body deteriorating effect, the Professor has revealed ant-aging drugs such as rapanrycin which is in use today. He has come up with two unique theories, one of anticancer and the other for anti-aging. One of them is called chemotherapeutic engineering for cancer and the other cell cyclotherapy for age. Since his entry into the Park Institute, he has made a remarkable contribution in the institute as far as research is concerned. Visit ResearchGate to keep up to date with Mikhail’s latest work.
From his many research results, Mikhail Blagosklonny has put together published materials, over 300 research articles, book chapters, and reviews. Together with his partners, he is a founder and editor as well as Editor- in –chief of the cell cycle. The Professor has also partnered with others as a co-editor and co-founder of aging Oncotaget and Oncoscience. He has been an associate editor for cancer biology and therapy, cancer research, cell death and differentiation, and the internal journal of cancer.
Mikhail Blagosklonny, who a professor in Oncology, is also the editor – in – Chief Oncotarget since the year 2002. His research studies in the behavior of cancer cells have made major strides towards the treatment and control of cancer cells in the body. He has put a lot of effort in understanding the relationship between the cancer cell and the normal cell. His studies and publications have many major contributions to healthcare. His major aim in researching is to come up with a solution for dealing with cancer and tumor cells to reduce the effect in the human body. There is so much that has been achieved not only for the treatment and control of cancer cells but also to the aging effect in the body. Read more about Mikhail at LinkedIn.com
Professor took his master’s degree in Internal Medicine and PhD. in experimental medicine both in the first state Pavlov and the State Medical University in St. Petersburg. He was first appointed an associate professor of medicine in NY medical college. He later took the Position on Senior Scientist at Ordway Research Institute, NY. He held this position up to the year 2009. He relinquished his position after he was appointed a Professor of Oncology at Roswell Park Cancer Institute. Professor Mikhail will be remembered for years because of his major contribution to the study of cancer as well as the understanding of the mechanism of aging. His contribution in the world of research has gone a long way in providing some healthcare solutions.